| ALBU | Albumin |
| AOPP | Advanced oxidation protein products |
| BIPED | Burden of disease, Investigative, Prognostic, Efficacy, Diagnostic |
| BMAC | Bone marrow aspirate concentrate |
| C2C | Type II collagen cleavage neoepitope |
| CRP | C-Reactive protein |
| CT | Control group |
| ELISA | Enzyme-linked immunosorbent assay |
| ERC | European research council |
| FDA | Food and drug administration |
| FRAP | Ferric reducing ability of plasma |
| GLOB | Globulins |
| HA | Hyaluronic acid |
| HDL | High-density lipoprotein |
| Hp | Haptoglobin |
| HyaNM | Hyaluronidase nanomotor |
| IA | Intraarticular |
| IBEC | Institute for bioengineering of catalonia |
| IGF-1 | Insulin-like growth factor 1 |
| IL-6 | Interleukin-6 |
| IM | Intramuscular |
| IO | Intraosseous |
| IQR | Interquartile range |
| IU | International units |
| MAPK | Mitogen-activated protein kinase |
| mCRP | Monomeric C-reactive protein |
| MMP | Matrix metalloproteinase |
| MSC | Mesenchymal stem cell |
| MSNP | Mesoporous silica nanoparticle |
| NB | Nanobots group |
| NF-κB | Nuclear factor kappa B |
| NM | Nanomotor |
| NSAID | Non-steroidal anti-inflammatory drug |
| OA | Osteoarthritis |
| PBS | Phosphate-buffered saline |
| pCRP | Pentameric C-reactive protein |
| PDGF | Platelet-derived growth factor |
| PON1 | Paraoxonase-1 |
| PRGF | Plasma rich in growth factors |
| PROT | Total protein |
| PRP | Platelet-rich plasma |
| ROS | Reactive oxygen species |
| SF | Synovial fluid |
| SPSS | Statistical package for social sciences |
| SYSADOA | Symptomatic slow-acting drugs for osteoarthritis |
| TEAC | Trolox equivalent antioxidant capacity |
| TGF-β | Transforming growth factor beta |
| Thiol | Total thiols |
| UrNM | Urease nanomotor |
| VEGF | Vascular endothelial growth factor |